Page not found

×

Warning message

Your search used too many AND/OR expressions. Only the first 7 terms were included in this search.

Search results

  1. mGlu3 NAMs as Therapeutics for Chemoresistant Tumors

    ... related to survival in patients with malignant gliomas (Cell Death and Differentiation, 2012, 1-12). The mechanism has been further studied to ...

    cttc_admin - 01/23/2024 - 4:42pm

  2. Applications now open for ASPIRE postdoctoral research fellowship to support path to entrepreneurship

    ... structured training opportunity to learn how to transform a technology into a company A biomedical sciences postdoc will be hired to ... to develop a commercialization strategy on a particular technology while immersing themselves in the local bioscience entrepreneurial ...

    sommers - 02/07/2024 - 10:47am

  3. Novel anti-platelet therapy for treatment of thrombosis, cardiovascular disease, and cerebrovascular injury

    Technology Description Cardiovascular disease remains one of the ... receptors 1 and 4 (PAR1, PAR4) are found on human platelets and mediate normal clot formation. They are also involved in ... Addressed One of the biggest limitations with anti-coagulant therapies today is the risk of bleeding associated with many ...

    cttc_admin - 01/23/2024 - 1:42pm

  4. Ph.D. to CEO: Entrepreneurial Transformation with the ASPIRE to Innovate Postdoctoral Fellowship Program

    ... ASPIRE Program , and Vanderbilt’s  Center for Technology Transfer and Commercialization will be supporting a biomedical ... research training as a graduate student in the Department of Cell and Developmental Biology. During her research training, she was actively ...

    sommers - 07/28/2021 - 10:05am

  5. CTTC commercialized 25 COVID-19-related discoveries, facilitated nine startups during record-setting year

    05/12/2021 The  Center for Technology Transfer and Commercialization  continued to play a pivotal role ... rehabilitation. IDBiologics  discovers and develops human monoclonal antibodies for the prevention, treatment and cure of ...

    sommers - 05/26/2021 - 10:39am

  6. Study shows new COVID target could improve vaccines

    ... concluded in a paper published last week in the journal  Cell . “Our team found a new site of vulnerability on the virus spike protein that can be targeted by protective human antibodies. This gives new insights into how our vaccines are working,” ...

    sommers - 04/12/2021 - 10:52am

  7. Dr. James Crowe Jr. receives SEC Faculty Achievement Award

    ... on the front lines of global research to eliminate human susceptibility to COVID-19 and other illnesses, is Vanderbilt ... the pinnacle of higher education’s mission to improve the human condition, and we could not be more delighted to provide this ... cited papers in leading scientific journals, including  Cell ,  Science  and in major medical journals such as  NEJM  and  ...

    sommers - 04/12/2021 - 10:53am

  8. Widely used software, developed by Young Lab, tops 1,000 academic licenses

    ... understand metabolic diseases or improve the productivity of cell-based bioprocesses.  “We developed it to serve our own research ... said Masood Ahammed Machingal, manager, digital technology licensing Building on the successes of non-patented intellectual ...

    sommers - 05/03/2021 - 10:24am

  9. Vanderbilt-developed obesity treatments will be advanced through collaboration with Soleno Therapeutics

    ... partnership, which is facilitated by the  Center for Technology Transfer and Commercialization,  will promote the development of ... said  Alan Bentley , assistant vice chancellor of technology transfer and enterprise development. “This project is ... translating academic research into meaningful outcomes for human health.” ...

    sommers - 02/25/2021 - 9:56am

  10. ‘Friendly’ bacteria may impact COVID severity

    ... and IMGSCT (Immunogenomics, Microbial Genetics and Single Cell Technology) cores, is co-investigator. Key resources include  BioVU , ...

    sommers - 03/16/2021 - 8:18am